We previously used a humanized mouse model to show that an LMP1-deleted EBV mutant that is non-transforming in vitro can cause lymphomas in vivo due to the ability of human CD40 ligand-expressing CD4 T cells to provide an alternative source of CD40 signaling [51,52]. Here, PDLIM7 is linked to lymphoma.